University of Tasmania
Browse

File(s) under permanent embargo

Influence of liquid and vapourized solvents on explosibility of pharmaceutical excipient dusts

journal contribution
posted on 2023-05-19, 10:43 authored by Hossain, MN, Amyotte, P, Abuswer, M, Dastidar, A, Faisal KhanFaisal Khan, Eckhoff, R, Chunmiao, Y
Hybrid mixtures of a combustible dust and flammable gas are found in many industrial processes. Such fuel systems are often encountered in the pharmaceutical industry when excipient (nonpharmaceutically active ingredient) powders undergo transfer in either a dry or solvent prewetted state into an environment possibly containing a flammable gas. The research described in this article simulated the conditions of the above scenarios with microcrystalline cellulose and lactose as excipients, and methanol, ethanol, and isopropanol as solvents. Standardized dust explosibility test equipment (Siwek 20-L explosion chamber, MIKE 3 apparatus, and BAM oven) and ASTM test protocols were used to determine the following explosibility parameters: maximum explosion pressure (Pmax), volume-normalized maximum rate of pressure rise (KSt), minimum explosible concentration (MEC), minimum ignition energy (MIE), and minimum ignition temperature (MIT). The experimental results demonstrate the significant enhancements in explosion likelihood and explosion severity brought about by solvent admixture in either mode. The extent of solvent influence was found to be specific to the given excipient and method of solvent addition. Solvent burning velocity considerations help to account for some of the experimental observations but for others, a more rigorous evaluation of solvent and excipient physical property data is needed.

History

Publication title

Process Safety Progress

Volume

33

Issue

4

Pagination

374-379

ISSN

1066-8527

Department/School

Australian Maritime College

Publisher

John Wiley & Sons, Inc.

Place of publication

USA

Rights statement

Copyright 2014 American Institute of Chemical Engineers

Repository Status

  • Restricted

Socio-economic Objectives

Human pharmaceutical products not elsewhere classified